Paliperidone Extended-release Tablets
Failed Dissolution Specifications; three month stability time point.
1,103 recalls, newest first
Failed Dissolution Specifications; three month stability time point.
Labeling: Incorrect or Missing Lot and/or Exp Date: the individual blisters are mislabeled with an incorrect lot number of 13560 rather than the correct lot number of 13650.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Subpotent drug
Super-Potent Drug: Out of specification for potency results (high) were obtained for one lot of morphine sulfate Inj.
Failed Impurities/Degradation Specifications: Observed levels of highest unknown impurity exceeding specification limit at the 3 month stability time point.
Subpotent Drug: failed at the 3 and 6 month stability time points.
Labeling: Label Mix-Up
Lack of Assurance of Sterility: Some single-use vials may be filled with water rather than the product solution and the firm cannot guarantee the sterility of the water-filled vials.
Microbial Contamination of a Non-Sterile Products: The product had a positive Staphylococcus aureus test result.
Defective Delivery System: Some units have actuation counters set to a number other than 60.
CGMP Deviations: Cylinders filled using out of date gauges.
Failed Impurities/Degradation Specifications: Out of specification test results for impurities during stability testing.